Pacemakers for Slow Heart Rate and Statins for Low LDL Cholesterol
Two leadless pacemakers (Micra and Nanostim) have had several years of testing. Both have been approved in Europe, and the Micra was approved in the U.S. in April 2016. When we prescribe a statin we are not just treating the numbers but targeting cardiovascular (CV) risk, with the primary aim of reducing heart attack and stroke. Whether to start statin therapy is dependent more on whether you fit into a high-risk group for developing CV events rather than the specific cholesterol numbers.